Riopan Plus Double Strength Interactions
There are 232 drugs known to interact with Riopan Plus Double Strength (magaldrate / simethicone), along with 3 disease interactions. Of the total drug interactions, 13 are major, 125 are moderate, and 94 are minor.
Medications known to interact with Riopan Plus Double Strength
Note: Showing generic names only.
A
- acalabrutinib
- acebutolol
- acetohexamide
- alendronate
- allopurinol
- alprazolam
- amphetamine
- amprenavir
- aspirin
- atazanavir
- atenolol
- atropine
- axitinib
- azithromycin
B
- bacampicillin
- baloxavir marboxil
- belumosudil
- benazepril
- benzphetamine
- betamethasone
- betaxolol
- bisacodyl
- bisoprolol
- bosutinib
C
- cabotegravir
- calcifediol
- calcitriol
- capecitabine
- captopril
- carbonyl iron
- carteolol
- carvedilol
- cefdinir
- cefditoren
- cefpodoxime
- cefuroxime
- ceritinib
- chenodiol
- chlordiazepoxide
- chloroquine
- chlorpromazine
- chlorpropamide
- cholecalciferol
- choline salicylate
- cimetidine
- cinoxacin
- ciprofloxacin
- clobazam
- clonazepam
- clorazepate
- cortisone
D
- dabigatran
- dabrafenib
- dasatinib
- deferasirox
- deferiprone
- delafloxacin
- delavirdine
- demeclocycline
- dexamethasone
- dextroamphetamine
- diazepam
- diflunisal
- digitoxin
- digoxin
- dihydrotachysterol
- divalproex sodium
- dolutegravir
- doxercalciferol
- doxycycline
- duloxetine
E
- eltrombopag
- elvitegravir
- enalapril
- enalaprilat
- enoxacin
- erdafitinib
- ergocalciferol
- erlotinib
- erythromycin
- estazolam
- etidronate
F
- famotidine
- ferric maltol
- ferrous fumarate
- ferrous gluconate
- ferrous sulfate
- fexofenadine
- fludrocortisone
- fluphenazine
- flurazepam
- fosinopril
G
- gabapentin
- gabapentin enacarbil
- gatifloxacin
- gefitinib
- gemifloxacin
- glimepiride
- glipizide
- glyburide
- grepafloxacin
H
I
- ibandronate
- indomethacin
- infigratinib
- iron bisglycinate
- iron polysaccharide
- iron protein succinylate
- itraconazole
K
L
- labetalol
- lactulose
- levodopa
- levofloxacin
- levoketoconazole
- levothyroxine
- levothyroxine / liothyronine
- liothyronine
- liotrix
- lisdexamfetamine
- lisinopril
- lomefloxacin
- lorazepam
M
- magnesium salicylate
- mefenamic acid
- mesoridazine
- methamphetamine
- methdilazine
- methenamine
- methotrimeprazine
- methylprednisolone
- metoprolol
- midazolam
- minocycline
- misoprostol
- moexipril
- moxifloxacin
- multivitamin with iron
- multivitamin with iron and fluoride
- multivitamin, prenatal
- mycophenolate mofetil
- mycophenolic acid
N
- nadolol
- nalidixic acid
- naproxen
- nebivolol
- neratinib
- nilotinib
- nirogacestat
- nitrofurantoin
- nizatidine
- norfloxacin
O
P
- pancreatin
- pancrelipase
- paricalcitol
- patiromer
- pazopanib
- penbutolol
- penicillamine
- peppermint oil
- perindopril
- perphenazine
- pexidartinib
- phenytoin
- pindolol
- ponatinib
- prednisolone
- prednisone
- prochlorperazine
- proguanil
- promazine
- promethazine
- propantheline
- propiomazine
- propranolol
- pyrimethamine
Q
R
- raltegravir
- ramipril
- ranitidine
- ranitidine bismuth citrate
- rifampin
- rilpivirine
- riociguat
- risedronate
- rosuvastatin
S
- salsalate
- sarecycline
- selpercatinib
- sodium polystyrene sulfonate
- sodium salicylate
- sodium thiosalicylate
- sotalol
- sotorasib
- sparfloxacin
- sparsentan
- sucralfate
T
- tacrolimus
- taletrectinib
- temazepam
- tetracycline
- thiethylperazine
- thioridazine
- thyroid desiccated
- ticlopidine
- tiludronate
- timolol
- tipranavir
- tolazamide
- tolbutamide
- trandolapril
- triamcinolone
- triazolam
- trifluoperazine
- triflupromazine
- trimeprazine
- trovafloxacin
U
V
Z
Riopan Plus Double Strength disease interactions
There are 3 disease interactions with Riopan Plus Double Strength (magaldrate / simethicone) which include:
Report options
QR code containing a link to this page
More about Riopan Plus Double Strength (magaldrate / simethicone)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.